SARS-CoV-2 Disguise Study

SARS-CoV-2 Positive Carriers Among Asymptomatic meDIcal employeeS in hiGh-volUme cardIovaScular cEnter

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04395794

Acronym

Disguise

Enrollment

900

Registered

2020-05-20

Start date

2020-05-07

Completion date

2020-11-30

Last updated

2020-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sars-CoV2

Brief summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomatic medical employees in non-profile infectious clinic, e.g. cardiovascular clinic, routinely working in the pandemic region with two million inhabitants. The aim is to test the percentage and increase of the SARS-CoV-2 positive carriers among asymptomatic medical employees in high-volume cardiovascular center in routine clinical practice.

Interventions

DIAGNOSTIC_TESTSARS-CoV-2-test

Nasopharyngeal and oropharyngeal testing for SARS-CoV-2

OTHERSARS-CoV-2 questionnaire survey

Questionnaire regarding SARS-CoV-2 symptoms and contact with COVID patients

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Asymptomatic medical employees of E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation * Filled questionnaire before SARS-CoV-2 testing * Nasopharyngeal and oropharyngeal testing for SARS-CoV-2 * Signed informed consent

Exclusion criteria

* Unwilling to participate

Design outcomes

Primary

Measure	Time frame	Description
SARS-CoV-2 positive test	8 weeks	Percentage of SARS-CoV-2 positive tests and increase of SARS-CoV-2 positive test between 1 st , 2 nd and 3 rd time frame testing

Secondary

Measure	Time frame	Description
Transformation	8 weeks	Percentage of transformation from asymptomatic SARS-CoV-2 positive carriers to symptomatic form
Predictors (asymptomatic)	8 weeks	Predictors of the asymptomatic SARS-CoV-2 positive carriers
Predictors (symptomatic)	8 weeks	Predictors of symptomatic form transformation
Percentage from different departments	8 weeks	Percentage of employees from different departments with SARS-CoV-2 positive carriers

Countries

Russia

Contacts

Primary ContactAlexander B Romanov, PhD

abromanov@mail.ru+79137172652

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026